Puma Biotechnology Inc (PBYI)
5.015
+0.02
(+0.50%)
USD |
NASDAQ |
Apr 19, 16:00
5.015
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Price to Book Value: 4.524 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 4.501 |
| April 17, 2024 | 4.664 |
| April 16, 2024 | 4.600 |
| April 15, 2024 | 4.826 |
| April 12, 2024 | 4.754 |
| April 11, 2024 | 4.952 |
| April 10, 2024 | 4.984 |
| April 09, 2024 | 5.259 |
| April 08, 2024 | 5.078 |
| April 05, 2024 | 5.106 |
| April 04, 2024 | 4.970 |
| April 03, 2024 | 4.826 |
| April 02, 2024 | 4.763 |
| April 01, 2024 | 4.763 |
| March 28, 2024 | 4.781 |
| March 27, 2024 | 5.033 |
| March 26, 2024 | 5.052 |
| March 25, 2024 | 5.042 |
| March 22, 2024 | 4.808 |
| March 21, 2024 | 4.826 |
| March 20, 2024 | 4.235 |
| March 19, 2024 | 3.879 |
| March 18, 2024 | 4.204 |
| March 15, 2024 | 4.510 |
| March 14, 2024 | 4.709 |
| Date | Value |
|---|---|
| March 13, 2024 | 4.808 |
| March 12, 2024 | 4.826 |
| March 11, 2024 | 4.952 |
| March 08, 2024 | 4.826 |
| March 07, 2024 | 5.187 |
| March 06, 2024 | 4.988 |
| March 05, 2024 | 4.673 |
| March 04, 2024 | 4.835 |
| March 01, 2024 | 5.313 |
| February 29, 2024 | 5.611 |
| February 28, 2024 | 5.954 |
| February 27, 2024 | 5.827 |
| February 26, 2024 | 5.845 |
| February 23, 2024 | 5.840 |
| February 22, 2024 | 5.269 |
| February 21, 2024 | 5.804 |
| February 20, 2024 | 6.054 |
| February 16, 2024 | 6.339 |
| February 15, 2024 | 6.232 |
| February 14, 2024 | 6.598 |
| February 13, 2024 | 5.537 |
| February 12, 2024 | 5.670 |
| February 09, 2024 | 5.153 |
| February 08, 2024 | 4.819 |
| February 07, 2024 | 4.494 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.737
Minimum
Oct 25 2023
55.58
Maximum
May 13 2020
14.25
Average
10.89
Median
Price to Book Value Benchmarks
| ADMA Biologics Inc | 10.58 |
| Regeneron Pharmaceuticals Inc | 3.788 |
| Sarepta Therapeutics Inc | 12.62 |
| CytomX Therapeutics Inc | -- |
| Mirum Pharmaceuticals Inc | 4.502 |
Price to Book Value Related Metrics
| PE Ratio | 11.14 |
| PS Ratio | 1.012 |
| Price to Free Cash Flow | 16.59 |
| Price | 5.015 |
| Earnings Yield | 8.97% |
| Market Cap | 241.76M |
| Operating PE Ratio | 7.168 |
| Normalized PE Ratio | 10.84 |